As of 2024-12-14, the Relative Valuation of Catalyst Pharmaceuticals Inc (CPRX) is 21.35 USD. This relative valuation is based on P/E multiples. With the latest stock price at 21.38 USD, the upside of Catalyst Pharmaceuticals Inc based on Relative Valuation is -0.1%.
The range of the Relative Valuation is 16.31 - 29.03 USD.
| Range | Selected | |
| Trailing P/E multiples | 35.6x - 50.8x | 37.4x |
| Forward P/E multiples | 24.4x - 41.1x | 32.0x |
| Fair Price | 16.31 - 29.03 | 21.35 |
| Upside | -23.7% - 35.8% | -0.1% |
| Date | P/E |
| 2024-12-13 | 37.44 |
| 2024-12-12 | 37.37 |
| 2024-12-11 | 38.47 |
| 2024-12-10 | 38.72 |
| 2024-12-09 | 38.07 |
| 2024-12-06 | 38.56 |
| 2024-12-05 | 38.00 |
| 2024-12-04 | 38.45 |
| 2024-12-03 | 38.02 |
| 2024-12-02 | 39.45 |
| 2024-11-29 | 38.65 |
| 2024-11-27 | 39.12 |
| 2024-11-26 | 38.40 |
| 2024-11-25 | 37.10 |
| 2024-11-22 | 37.61 |
| 2024-11-21 | 36.98 |
| 2024-11-20 | 37.03 |
| 2024-11-19 | 37.46 |
| 2024-11-18 | 36.46 |
| 2024-11-15 | 36.07 |
| 2024-11-14 | 37.98 |
| 2024-11-13 | 39.92 |
| 2024-11-12 | 40.34 |
| 2024-11-11 | 41.06 |
| 2024-11-08 | 41.90 |
| 2024-11-07 | 40.71 |
| 2024-11-06 | 39.77 |
| 2024-11-05 | 38.45 |
| 2024-11-04 | 38.09 |
| 2024-11-01 | 38.33 |
| 2024-10-31 | 38.17 |
| 2024-10-30 | 37.75 |
| 2024-10-29 | 38.12 |
| 2024-10-28 | 38.28 |
| 2024-10-25 | 37.58 |
| 2024-10-24 | 37.49 |
| 2024-10-23 | 37.37 |
| 2024-10-22 | 37.58 |
| 2024-10-21 | 36.81 |
| 2024-10-18 | 37.19 |
| 2024-10-17 | 37.05 |
| 2024-10-16 | 37.95 |
| 2024-10-15 | 37.09 |
| 2024-10-14 | 36.14 |
| 2024-10-11 | 35.37 |
| 2024-10-10 | 34.86 |
| 2024-10-09 | 34.97 |
| 2024-10-08 | 35.16 |
| 2024-10-07 | 34.55 |
| 2024-10-04 | 35.02 |